Compounds > lapatinib
Page last updated: 2024-09-05

lapatinib and flufenamic acid

lapatinib has been researched along with flufenamic acid in 1 studies

Compound Research Comparison

Studies
(lapatinib)		Trials
(lapatinib)		Recent Studies (post-2010)
(lapatinib)		Studies
(flufenamic acid)		Trials
(flufenamic acid)		Recent Studies (post-2010) (flufenamic acid)
1,9193051,4421,05869202

Protein Interaction Comparison

ProteinTaxonomylapatinib (IC50)flufenamic acid (IC50)
Aldo-keto reductase family 1 member B10Homo sapiens (human)0.76
TransthyretinHomo sapiens (human)2.9
Prostaglandin G/H synthase 1Homo sapiens (human)2.615
Prostaglandin G/H synthase 2Homo sapiens (human)3.112
Aldo-keto reductase family 1 member C3Homo sapiens (human)1.4901
Aldo-keto reductase family 1 member C2 Homo sapiens (human)1.3467
Aldo-keto reductase family 1 member C1Homo sapiens (human)2.64

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ekins, S; Williams, AJ; Xu, JJ1

Other Studies

1 other study(ies) available for lapatinib and flufenamic acid

ArticleYear
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010